Join
Live feed
·
PRReleasevia Quantisnow
Insmed Incorporated logo

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease

ByQuantisnow·Wall Street's wire, on your screen.
INSM· Insmed Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INSM (Insmed Incorporated) and more on Quantisnow.